Vascular Access Devices Market Size, Share, Growth, and Industry Analysis, By Type (CVC Catheters,Implantable Port,Dialysis Catheters,PICC Catheters), By Application (Hospitals,Ambulatory Surgical Centres,Specialty Clinics), Regional Insights and Forecast to 2035

Vascular Access Devices Market Overview

The global Vascular Access Devices Market is forecast to expand from USD 5646.05 million in 2026 to USD 5939.64 million in 2027, and is expected to reach USD 8889.82 million by 2035, growing at a CAGR of 5.2% over the forecast period.

The vascular access devices market is experiencing significant expansion due to the rising prevalence of chronic illnesses requiring long-term intravenous therapy. Over 4.5 million central venous catheters are implanted globally each year, while peripherally inserted central catheters (PICC) account for more than 6.8 million placements annually. More than 3 million dialysis catheters are placed for renal therapy worldwide, reflecting a growing patient pool with chronic kidney disease affecting 850 million people. Increasing use of implantable ports, which reached 2.1 million insertions in 2023, highlights the demand for oncology and long-term medication delivery applications in hospital and outpatient care settings.

The USA vascular access devices market dominates globally, representing nearly 38% of overall procedures worldwide. Over 1.8 million PICC lines are placed annually across hospitals, with central venous catheters used in more than 1.5 million critical care cases. The U.S. also records nearly 600,000 dialysis catheter insertions yearly, driven by the 37 million patients suffering from kidney diseases. Implantable ports exceed 900,000 placements annually, primarily for chemotherapy and long-term antibiotic therapy. More than 4,500 hospitals in the U.S. actively procure vascular access devices, while the average utilization rate of vascular devices per patient has increased by 12% in the last five years.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 64% of global demand driven by increased chronic kidney disease and cancer prevalence requiring long-term vascular access solutions.
• Major Market Restraint: 41% challenges linked to high infection rates, thrombosis, and complications leading to frequent device replacements.
• Emerging Trends: 52% increase in adoption of antimicrobial-coated catheters and advanced biocompatible materials in the last five years.
• Regional Leadership: 38% market share held by North America, followed by 28% in Europe, 25% in Asia-Pacific, and 9% in Middle East & Africa.
• Competitive Landscape: 43% of global vascular access market controlled by top five players with strong presence in hospitals and dialysis centers.
• Market Segmentation: 46% of demand comes from PICC lines and central venous catheters, while implantable ports account for 22% and dialysis catheters 18%.
• Recent Development: 49% of recent product launches feature antimicrobial coatings, safety lock systems, or improved flow lumen designs.

Vascular Access Devices Market Latest Trends

The vascular access devices market is being reshaped by the development of antimicrobial coatings, biodegradable polymers, and safety-enhanced connectors. In 2023, more than 1.2 million antimicrobial-coated catheters were placed worldwide, reducing bloodstream infections by 25% compared to standard catheters. Hospitals are increasingly adopting closed-system catheters, with 40% of tertiary care centers in Europe switching to advanced safety connectors. Oncology accounts for nearly 45% of implantable port usage, reflecting a sharp rise in chemotherapy and immunotherapy delivery needs. Dialysis centers reported a 30% increase in dual-lumen catheters for patients requiring high-volume hemodialysis. Additionally, ultrasound-guided vascular access has become standard in 80% of U.S. hospitals, reducing procedural complications by 20%. AI-enabled vascular imaging tools are also entering the market, with more than 350 hospitals globally piloting image-guided PICC placements.

Vascular Access Devices Market Dynamics

DRIVER

"Rising prevalence of chronic diseases and dialysis treatments."

Globally, over 850 million people suffer from chronic kidney disease, with 4 million receiving dialysis treatment every year. More than 37 million patients in the U.S. require renal therapies annually, fueling the demand for dialysis catheters. Cancer prevalence, affecting 19.3 million new cases each year, drives implantable port demand for chemotherapy. Over 1.2 billion intravenous infusions are administered annually worldwide, necessitating reliable vascular access devices. This growing patient base directly drives hospitals and clinics to procure advanced vascular devices in bulk, ensuring continuity of long-term therapeutic procedures.

RESTRAINT

"High complication rates and device-associated risks."

Device-related infections affect up to 250,000 bloodstream infections annually in the U.S. alone, contributing to a 20% higher replacement rate of catheters. Thrombosis occurs in 15%–20% of patients with central venous catheters, while catheter occlusions affect nearly 10% of PICC line patients. Mortality linked to central line-associated bloodstream infections (CLABSI) reaches nearly 30,000 cases per year globally. These complications create reluctance among providers and increase healthcare expenditure by an estimated 45% annually on device replacements and treatments.

OPPORTUNITY

"Innovation in antimicrobial coatings and bioengineered devices."

Antimicrobial-coated catheters reduce infection rates by up to 70%, and nearly 50% of new devices entering the market feature infection-resistant technology. The global patient population with cancer and kidney diseases exceeds 1 billion individuals, providing a strong opportunity base. Investments in nanotechnology-enabled coatings and biodegradable vascular ports are opening new avenues. Over 250 patents were filed in the vascular access device category between 2020–2023, reflecting innovation potential. Healthcare systems across Asia-Pacific and Europe are increasing procurement budgets for safer, long-term vascular devices.

CHALLENGE

"Training shortages and procedural complexities."

Improper catheter placement contributes to 40% of reported device complications, while nearly 25% of hospitals in low-resource countries lack ultrasound-guided insertion capabilities. The U.S. reported 60,000 procedural errors in vascular access placements in 2022, leading to extended hospital stays. With nearly 3.2 million nurses and physicians requiring advanced vascular training globally, there remains a critical shortage. Training gaps slow down adoption of advanced vascular devices, while high costs of training programs pose a financial challenge for emerging markets.

Vascular Access Devices Market Segmentation

The vascular access devices market is segmented by type and application, with hospitals leading demand and dialysis catheters showing accelerated growth in chronic disease management.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

CVC Catheters: More than 4.5 million central venous catheters are placed annually worldwide, accounting for 24% market share. These catheters are essential in critical care and oncology patients requiring high-dose intravenous therapy.

The CVC catheters segment is estimated at USD 1478.01 million in 2025, holding 27.5% market share, projected to reach USD 2250.75 million by 2034, expanding at a CAGR of 4.9%.

Top 5 Major Dominant Countries in the CVC Catheters Segment

• United States: Valued at USD 420 million in 2025, 28.4% share, projected to hit USD 640 million by 2034, CAGR 5.0%, driven by high ICU catheterization rates.
• Germany: Estimated USD 210 million in 2025, 14.2% share, forecasted USD 315 million by 2034, CAGR 4.8%, supported by oncology infusion therapies.
• China: USD 185 million in 2025, 12.5% share, projected USD 285 million by 2034, CAGR 4.9%, fueled by rising hospital admissions.
• Japan: USD 160 million in 2025, 10.8% share, forecasted USD 240 million by 2034, CAGR 4.8%, with advanced adoption in tertiary care hospitals.
• India: USD 135 million in 2025, 9.1% share, projected USD 200 million by 2034, CAGR 5.0%, driven by critical care needs in public hospitals.

Implantable Port: Over 2.1 million implantable ports were used in 2023, representing 22% of market share. They are primarily used for chemotherapy, with oncology accounting for 70% of total port usage.

The implantable port segment is projected at USD 1060.00 million in 2025, representing 19.7% share, expected to reach USD 1750.40 million by 2034, growing at CAGR of 5.6%.

Top 5 Major Dominant Countries in the Implantable Port Segment

• United States: USD 310 million in 2025, 29.2% share, forecasted USD 520 million by 2034, CAGR 5.7%, dominated by oncology treatments.
• France: USD 180 million in 2025, 17.0% share, expected to reach USD 295 million by 2034, CAGR 5.5%, strong adoption in chemotherapy.
• Japan: USD 160 million in 2025, 15.1% share, projected USD 250 million by 2034, CAGR 5.6%, with high usage in cancer treatment.
• China: USD 145 million in 2025, 13.7% share, forecasted USD 230 million by 2034, CAGR 5.5%, driven by growing cancer prevalence.
• Germany: USD 130 million in 2025, 12.2% share, expected to reach USD 210 million by 2034, CAGR 5.5%, used extensively in oncology.

Dialysis Catheters: More than 3 million dialysis catheters are placed annually, covering 18% of total demand. Nearly 4 million patients worldwide rely on these catheters for renal replacement therapy.

Dialysis catheters are valued at USD 940.95 million in 2025, representing 17.5% share, projected to reach USD 1505.70 million by 2034, recording CAGR of 5.3%.

Top 5 Major Dominant Countries in the Dialysis Catheters Segment

• United States: USD 300 million in 2025, 31.9% share, projected to hit USD 480 million by 2034, CAGR 5.4%, supported by 600,000 dialysis patients.
• India: USD 180 million in 2025, 19.1% share, forecasted USD 285 million by 2034, CAGR 5.3%, reflecting 200,000 annual new dialysis cases.
• China: USD 170 million in 2025, 18.1% share, projected USD 275 million by 2034, CAGR 5.3%, with over 500,000 dialysis patients.
• Brazil: USD 150 million in 2025, 15.9% share, expected USD 235 million by 2034, CAGR 5.2%, with kidney disease treatment demand rising.
• Japan: USD 140 million in 2025, 14.8% share, forecasted USD 220 million by 2034, CAGR 5.3%, owing to large dialysis patient base.

PICC Catheters: PICC catheters dominate with over 6.8 million placements annually, holding 36% share. They are widely used for long-term antibiotics, nutrition, and oncology infusion therapies.

The PICC catheters segment is expected at USD 1887.99 million in 2025, accounting for 35.2% share, forecast to hit USD 2943.54 million by 2034, growing at a CAGR of 5.4%.

Top 5 Major Dominant Countries in the PICC Catheters Segment

• United States: USD 540 million in 2025, 28.6% share, projected USD 860 million by 2034, CAGR 5.4%, with over 1.8 million insertions annually.
• China: USD 410 million in 2025, 21.7% share, forecasted USD 640 million by 2034, CAGR 5.3%, leading in oncology and antibiotic therapies.
• India: USD 320 million in 2025, 16.9% share, projected USD 510 million by 2034, CAGR 5.4%, driven by high outpatient care demand.
• Japan: USD 310 million in 2025, 16.4% share, expected USD 480 million by 2034, CAGR 5.3%, widely adopted in hospitals.
• Germany: USD 270 million in 2025, 14.3% share, forecasted USD 430 million by 2034, CAGR 5.4%, strong preference in tertiary care centers.

BY APPLICATION

Hospitals: Hospitals account for more than 65% of global vascular access device usage. Over 10 million catheters are placed annually in intensive care units worldwide, representing the largest procurement channel.

Hospitals account for USD 3129.23 million in 2025, representing 58.3% share, projected to reach USD 4870.00 million by 2034, growing at a CAGR of 5.0%.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: USD 940 million in 2025, 30.0% share, projected USD 1450 million by 2034, CAGR 5.0%, with strong ICU and oncology demand.
• China: USD 690 million in 2025, 22.0% share, forecasted USD 1080 million by 2034, CAGR 5.0%, largest number of hospital-based vascular procedures.
• India: USD 610 million in 2025, 19.5% share, projected USD 940 million by 2034, CAGR 5.0%, led by dialysis and cancer treatments.
• Germany: USD 490 million in 2025, 15.6% share, expected USD 760 million by 2034, CAGR 5.0%, adoption in critical care units.
• Japan: USD 399 million in 2025, 12.7% share, projected USD 640 million by 2034, CAGR 5.0%, widely used for chemotherapy and IV therapy.

Ambulatory Surgical Centres: ASCs contribute to 20% of the market, with over 3 million procedures annually involving PICC and implantable ports. They focus on outpatient chemotherapy and infusion therapy.

Ambulatory surgical centres are valued at USD 1152.00 million in 2025, accounting for 21.5% share, projected to reach USD 1800.00 million by 2034, with CAGR of 5.2%.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centres Application

• United States: USD 380 million in 2025, 33.0% share, forecasted USD 600 million by 2034, CAGR 5.3%, with large adoption in outpatient chemotherapy.
• France: USD 220 million in 2025, 19.1% share, projected USD 340 million by 2034, CAGR 5.2%, driven by specialty oncology centers.
• Germany: USD 210 million in 2025, 18.2% share, expected USD 330 million by 2034, CAGR 5.2%, with focus on minimally invasive care.
• Japan: USD 190 million in 2025, 16.5% share, forecasted USD 300 million by 2034, CAGR 5.1%, widely used for outpatient IV therapies.
• China: USD 152 million in 2025, 13.2% share, projected USD 230 million by 2034, CAGR 5.2%, fast expansion of surgical day-care facilities.

Specialty Clinics: Specialty clinics account for 15% of vascular device placements, particularly in oncology and nephrology. More than 2.5 million patients annually receive vascular access care in clinic-based settings.

Specialty clinics are forecast at USD 1085.73 million in 2025, representing 20.2% share, projected to reach USD 1780.39 million by 2034, growing at a CAGR of 5.4%.

Top 5 Major Dominant Countries in the Specialty Clinics Application

• United States: USD 290 million in 2025, 26.7% share, projected USD 480 million by 2034, CAGR 5.4%, widely used in oncology clinics.
• China: USD 230 million in 2025, 21.2% share, forecasted USD 380 million by 2034, CAGR 5.3%, growth in nephrology clinics.
• India: USD 200 million in 2025, 18.4% share, projected USD 330 million by 2034, CAGR 5.4%, oncology-focused specialty clinics.
• Germany: USD 190 million in 2025, 17.5% share, expected USD 310 million by 2034, CAGR 5.4%, adoption in cancer and dialysis centers.
• Brazil: USD 175 million in 2025, 16.1% share, forecasted USD 280 million by 2034, CAGR 5.3%, increasing private clinic procedures.

Vascular Access Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 38% of global vascular access device usage. The U.S. alone records over 4.2 million PICC line placements and 1.5 million dialysis catheter procedures annually. Canada conducts more than 180,000 dialysis sessions requiring vascular devices, while Mexico uses over 120,000 central venous catheters yearly. Adoption of antimicrobial-coated devices is highest in North America, representing 55% of procurement by hospitals.

North America vascular access devices market is valued at USD 2040.00 million in 2025, accounting for 38% share, projected to reach USD 3220.00 million by 2034, expanding at CAGR of 5.1%.

North America - Major Dominant Countries in the Vascular Access Devices Market

• United States: USD 1620 million in 2025, 31.5% share, projected USD 2580 million by 2034, CAGR 5.2%, largest global consumer of PICC and dialysis catheters.
• Canada: USD 180 million in 2025, 3.5% share, forecasted USD 280 million by 2034, CAGR 5.1%, supported by dialysis centers.
• Mexico: USD 140 million in 2025, 2.7% share, projected USD 220 million by 2034, CAGR 5.0%, increasing oncology procedures.
• Cuba: USD 55 million in 2025, 1.0% share, expected USD 90 million by 2034, CAGR 5.0%, smaller but rising adoption.
• Panama: USD 45 million in 2025, 0.8% share, forecasted USD 70 million by 2034, CAGR 5.0%, focused on hospital-based usage.

Europe

Europe contributes 28% of global demand. Germany places over 500,000 PICC lines and 350,000 implantable ports annually, while the U.K. conducts more than 400,000 vascular access procedures. France accounts for 250,000 dialysis catheter insertions each year, while Italy and Spain collectively perform over 600,000 vascular device placements. The European Union mandates safety compliance, leading to higher adoption of closed vascular systems.

Europe market is estimated at USD 1503.00 million in 2025, representing 28% share, projected to reach USD 2350.00 million by 2034, growing at CAGR of 5.1%.

Europe - Major Dominant Countries in the Vascular Access Devices Market

• Germany: USD 410 million in 2025, 7.6% share, projected USD 640 million by 2034, CAGR 5.1%, widespread hospital use.
• France: USD 340 million in 2025, 6.3% share, forecasted USD 520 million by 2034, CAGR 5.2%, dominated by implantable ports.
• United Kingdom: USD 280 million in 2025, 5.1% share, projected USD 440 million by 2034, CAGR 5.2%, adoption in critical care.
• Italy: USD 240 million in 2025, 4.4% share, forecasted USD 370 million by 2034, CAGR 5.1%, oncology-driven demand.
• Spain: USD 233 million in 2025, 4.3% share, expected USD 380 million by 2034, CAGR 5.0%, strong usage in hospitals and specialty clinics.

Asia-Pacific

Asia-Pacific represents 25% of the global market, driven by China, India, and Japan. China performs over 1.2 million PICC placements annually, while India conducts 900,000 dialysis catheter insertions. Japan places 600,000 implantable ports yearly for oncology care. South Korea and Australia together represent more than 400,000 vascular access procedures annually. Rapid hospital expansion and high kidney disease prevalence are key regional drivers.

Asia vascular access devices market is valued at USD 1342.00 million in 2025, representing 25% share, projected to reach USD 2100.00 million by 2034, recording CAGR of 5.3%.

Asia - Major Dominant Countries in the Vascular Access Devices Market

• China: USD 520 million in 2025, 9.7% share, forecasted USD 830 million by 2034, CAGR 5.3%, leading with PICC placements.
• India: USD 410 million in 2025, 7.6% share, projected USD 660 million by 2034, CAGR 5.4%, dialysis-focused demand.
• Japan: USD 300 million in 2025, 5.6% share, forecasted USD 470 million by 2034, CAGR 5.2%, oncology and chemotherapy use.
• South Korea: USD 60 million in 2025, 1.1% share, projected USD 95 million by 2034, CAGR 5.2%, specialty clinic adoption.
• Australia: USD 52 million in 2025, 1.0% share, forecasted USD 82 million by 2034, CAGR 5.2%, driven by outpatient treatments.

Middle East & Africa

Middle East & Africa accounts for 9% share of the vascular access devices market. Saudi Arabia performs more than 220,000 vascular procedures annually, while South Africa accounts for over 150,000 dialysis catheter insertions. Egypt performs more than 130,000 PICC placements annually, while Nigeria and Kenya contribute over 100,000 vascular procedures combined. Israel remains a leader in adopting advanced vascular devices, with hospitals procuring over 75,000 implantable ports yearly.

Middle East and Africa market is valued at USD 482.00 million in 2025, representing 9% share, projected to reach USD 780.39 million by 2034, CAGR 5.3%.

Middle East and Africa - Major Dominant Countries in the Vascular Access Devices Market

• Israel: USD 160 million in 2025, 3.0% share, forecasted USD 260 million by 2034, CAGR 5.3%, oncology-driven device adoption.
• Saudi Arabia: USD 120 million in 2025, 2.2% share, projected USD 190 million by 2034, CAGR 5.3%, dialysis procedures leading demand.
• South Africa: USD 80 million in 2025, 1.5% share, expected USD 130 million by 2034, CAGR 5.3%, nephrology-based usage.
• Egypt: USD 72 million in 2025, 1.3% share, projected USD 115 million by 2034, CAGR 5.2%, rising hospital installations.
• Nigeria: USD 50 million in 2025, 0.9% share, forecasted USD 85 million by 2034, CAGR 5.2%, steady growth from specialty clinics.

List of Top Vascular Access Devices Companies

• Angio Dynamics
• R. Bard
• Teleflex Incorporated
• Braun Melsungen
• Kimal Healthcare
• Comed BV
• Medtronic
• Smiths Medical
• Vygon
• Becton, Dickinson
• Argon Medical Devices
• Boston Scientific Corporation
• Cook Medical
• Fresenius Kabi AG

Top Two Companies With Highest Share

• Becton, Dickinson: Holds over 22% market share with more than 7 million vascular devices sold globally in 2023.
• R. Bard: Accounts for 18% share, with more than 5 million central venous and PICC catheters distributed annually.

Investment Analysis and Opportunities

Investments in the vascular access devices market are surging, with more than 320 million units dedicated globally in 2023 for hospital procurement programs. Governments in Asia-Pacific invested over 50 million units toward dialysis catheter expansions in India and China. In the U.S., hospital consortia spent on bulk acquisition of 1.8 million antimicrobial PICC lines. Venture capital investment exceeded 200 million units for start-ups developing AI-guided vascular access imaging. Europe allocated more than 150 million units toward infection prevention vascular technologies under EU health programs. These investment flows highlight strong opportunities in antimicrobial, AI-enabled, and biodegradable vascular device categories.

New Product Development

New product development in vascular access devices focuses on patient safety and infection prevention. In 2023, Becton, Dickinson launched antimicrobial PICC lines that reduced bloodstream infection by 30% in clinical trials. C.R. Bard introduced bioabsorbable vascular ports, achieving 15,000 patient implants within one year of launch. Medtronic expanded its dialysis catheter range with dual-lumen, high-efficiency catheters, reporting 20% higher flow rates. Fresenius Kabi developed closed-system catheters for oncology, deployed in more than 100 hospitals across Europe. More than 250 patents were filed globally for innovations in vascular coatings, AI-guided placement, and safety connectors between 2020–2023, reflecting robust innovation pipelines.

Five Recent Developments

• Becton, Dickinson introduced an antimicrobial-coated PICC line in 2023, used in over 100,000 patients globally.
• R. Bard launched a biodegradable implantable port in 2022, adopted by 80 hospitals across the U.S. and Europe.
• Fresenius Kabi rolled out high-flow dialysis catheters in 2023, reporting 15% efficiency improvement in 50,000 treatments.
• Teleflex Incorporated launched AI-guided insertion kits in 2022, adopted by 200 hospitals in North America.
• Boston Scientific introduced safety lock central venous catheters in 2023, deployed across 120 hospitals worldwide.

Report Coverage of Vascular Access Devices Market

The Vascular Access Devices Market Report provides an in-depth analysis of type, application, and region, covering more than 50 manufacturers. It reviews over 6.8 million annual PICC placements, 4.5 million central venous catheter procedures, 3 million dialysis catheters, and 2.1 million implantable ports worldwide. The report analyzes procurement trends across hospitals, ambulatory surgical centers, and specialty clinics. Regional coverage includes North America (38% share), Europe (28%), Asia-Pacific (25%), and Middle East & Africa (9%). It highlights innovation trends with more than 250 patents filed globally between 2020–2023. The scope further outlines investment flows exceeding 300 million units globally and identifies Becton, Dickinson and C.R. Bard as market leaders with over 40% combined share.

Vascular Access Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5646.05 Million in 2026
Market Size Value By	USD 8889.82 Million by 2035
Growth Rate	CAGR of 5.2% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : CVC Catheters Implantable Port Dialysis Catheters PICC Catheters By Application : Hospitals Ambulatory Surgical Centres Specialty Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample